[
  {
    "ts": null,
    "headline": "Stock Market Today: Indexes Mixed; Coherent Hits 3 Sell Signals But New IPO Bullish Jumps 10%; 3 Growth Stocks Set Up Entries",
    "summary": "In the stock market today, the Dow Jones index trimmed losses made after a PPI inflation report. Coherent plunged on earnings. Bullish rose 10%.",
    "url": "https://finnhub.io/api/news?id=f94cb20e5463559ab635bfc5eb14f97b0bd80643157a30b2088f58a530ac2700",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755204844,
      "headline": "Stock Market Today: Indexes Mixed; Coherent Hits 3 Sell Signals But New IPO Bullish Jumps 10%; 3 Growth Stocks Set Up Entries",
      "id": 136368178,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "In the stock market today, the Dow Jones index trimmed losses made after a PPI inflation report. Coherent plunged on earnings. Bullish rose 10%.",
      "url": "https://finnhub.io/api/news?id=f94cb20e5463559ab635bfc5eb14f97b0bd80643157a30b2088f58a530ac2700"
    }
  },
  {
    "ts": null,
    "headline": "Insulet's (NASDAQ:PODD) Conservative Accounting Might Explain Soft Earnings",
    "summary": "NasdaqGS:PODD 1 Year Share Price vs Fair Value Explore Insulet's Fair Values from the Community and select yours...",
    "url": "https://finnhub.io/api/news?id=beb8f077dd83bafd63957603562074e57a0fce07e8811cccc8ff9a63dff98836",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755196879,
      "headline": "Insulet's (NASDAQ:PODD) Conservative Accounting Might Explain Soft Earnings",
      "id": 136368632,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "NasdaqGS:PODD 1 Year Share Price vs Fair Value Explore Insulet's Fair Values from the Community and select yours...",
      "url": "https://finnhub.io/api/news?id=beb8f077dd83bafd63957603562074e57a0fce07e8811cccc8ff9a63dff98836"
    }
  },
  {
    "ts": null,
    "headline": "Insulet Corp. stock underperforms Thursday when compared to competitors despite daily gains",
    "summary": "Insulet Corp. stock underperforms Thursday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=9b93c1906c257e4f021f53dc14be60d59ccbca4f44fab6fb948dbc1134ee1e62",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755191160,
      "headline": "Insulet Corp. stock underperforms Thursday when compared to competitors despite daily gains",
      "id": 136398185,
      "image": "",
      "related": "PODD",
      "source": "MarketWatch",
      "summary": "Insulet Corp. stock underperforms Thursday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=9b93c1906c257e4f021f53dc14be60d59ccbca4f44fab6fb948dbc1134ee1e62"
    }
  },
  {
    "ts": null,
    "headline": "The Top 5 Analyst Questions From Insulet’s Q2 Earnings Call",
    "summary": "Insulet’s second quarter delivered notable revenue and profit outperformance, with the company’s results exceeding Wall Street’s expectations and the stock responding with a significant positive move. Management credited the broad-based adoption of Omnipod 5, particularly among new users in both type 1 and type 2 diabetes segments, as well as ongoing international expansion. CEO Ashley McEvoy emphasized, “We grew both year-over-year and sequentially in new customer starts across all of our strat",
    "url": "https://finnhub.io/api/news?id=dee1f793de06f8f0ed0294ddafe1cf07941f5df2730037ec28697a173e274036",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755149650,
      "headline": "The Top 5 Analyst Questions From Insulet’s Q2 Earnings Call",
      "id": 136345151,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Insulet’s second quarter delivered notable revenue and profit outperformance, with the company’s results exceeding Wall Street’s expectations and the stock responding with a significant positive move. Management credited the broad-based adoption of Omnipod 5, particularly among new users in both type 1 and type 2 diabetes segments, as well as ongoing international expansion. CEO Ashley McEvoy emphasized, “We grew both year-over-year and sequentially in new customer starts across all of our strat",
      "url": "https://finnhub.io/api/news?id=dee1f793de06f8f0ed0294ddafe1cf07941f5df2730037ec28697a173e274036"
    }
  }
]